OUR PRODUCTS

MOBILE APPS

GENERAL INFO

VRTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRTX is expected to report earnings to rise 2.43% to $4.63 per share on October 29

Vertex Pharmaceuticals VRTX Stock Earnings Reports

Q3'25

Est.

$4.63

Q2'25

Beat

by $0.25

Q1'25

Missed

by $0.20

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.30

The last earnings report on August 04 showed earnings per share of $4.52, beating the estimate of $4.27. With 135.03K shares outstanding, the current market capitalization sits at 93.98B.

View a ticker or compare two or three

Compare

VRTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VRTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRTX showed earnings on August 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

50 Northern Avenue

Phone

+1 617 341-6100

Employees

5400

Web

https://www.vrtx.com